Phoenix Financial (PHOE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
30 Oct, 2026Executive summary
H1 comprehensive income attributable to shareholders was NIS 667m, with 12.8% ROE; Q2 comprehensive income was NIS 383m, with 15.1% ROE.
H1 core income reached NIS 869m and core ROE was 16.7%; Q2 core comprehensive income was NIS 548m, with 21.9% core ROE.
AUM reached NIS 480bn, up 11% in H1, including growth from the Psagot acquisition; core growth put 2025 targets ahead of schedule.
Ownership became dispersed after international investors acquired shares from former controlling shareholders.
Financial highlights
H1 net income attributable to shareholders was NIS 636m versus NIS 1.6m; Q2 was NIS 418m versus NIS 59m.
H1 total income was NIS 13.83bn versus NIS 12.05bn; Q2 total income was NIS 4.96bn versus NIS 7.83bn, reflecting lower investment income.
H1 income per share was NIS 2.65; basic EPS was NIS 2.51. Q2 income per share was NIS 1.52 and basic EPS was NIS 2.75.
Adjusted EBITDA for Asset Management, Distribution and Credit was NIS 567m in H1, versus NIS 459m a year earlier.
Shareholders’ equity was NIS 10.8bn at June 30, 2024.
Outlook and guidance
Existing 2025 targets include NIS 1.3bn–1.5bn core comprehensive income, NIS 450bn–550bn AUM and 12%–15% ROE; updated targets and a roadmap were due September 9, 2024.
Core ROE of 16.7% exceeded the 2025 target range, and AUM and core income targets were described as achieved ahead of schedule.
IFRS 17 and IFRS 9 adoption in Israel was scheduled for January 1, 2025, with transition date January 1, 2024.
Lower business and developer credit demand and cautious underwriting were expected to constrain credit-portfolio growth.
Latest events from Phoenix Financial
- Market losses cut 2022 comprehensive income to NIS 1,124m despite operating growth.PHOE
Q4 2022 - Market losses weighed on income, while operations grew and AUM reached NIS 364b.PHOE
Q3 2022 - Core growth and higher rates partly offset capital-market losses that cut H1 income.PHOE
Q2 2022 - 15.5% ROE as higher-rate benefits offset market losses and P&C pressures.PHOE
Q1 2022 - Adjusted operating and core income rose as market effects weighed on 9M results.PHOE
Q3 2023 - Core income rose 34% as a NIS 317m market impact weighed on Q1 results.PHOE
Q1 2023 - Core income rose 15% to NIS 626m despite weaker market-related returns.PHOE
Q1 2025 - H1 core income rose 22% to NIS 1.318bn as ROE reached 26.9% and payouts expanded.PHOE
Q2 2025 - Core income reached NIS 1.985bn for 9M; 2028 target is NIS 3.3–3.5bn.PHOE
Q3 2025